These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 29753747)

  • 1. HOXC10 promotes gastric cancer cell invasion and migration via regulation of the NF-κB pathway.
    Yao S; He L; Zhang Y; Ye L; Lai Y; Huang L; Wu L; Wu G; Zhu S
    Biochem Biophys Res Commun; 2018 Jun; 501(3):628-635. PubMed ID: 29753747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HOXC10 promotes cell migration, invasion, and tumor growth in gastric carcinoma cells through upregulating proinflammatory cytokines.
    Li J; Tong G; Huang C; Luo Y; Wang S; Zhang Y; Cheng B; Zhang Z; Wu X; Liu Q; Li M; Li L; Ni B
    J Cell Physiol; 2020 Apr; 235(4):3579-3591. PubMed ID: 31552684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HOXC10 overexpression promotes cell proliferation and migration in gastric cancer.
    Kim J; Bae DH; Kim JH; Song KS; Kim YS; Kim SY
    Oncol Rep; 2019 Jul; 42(1):202-212. PubMed ID: 31115563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RPS15A promotes gastric cancer progression via activation of the Akt/IKK-β/NF-κB signalling pathway.
    Liu C; He X; Liu X; Yu J; Zhang M; Yu F; Wang Y
    J Cell Mol Med; 2019 Mar; 23(3):2207-2218. PubMed ID: 30661291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MTMR2 promotes invasion and metastasis of gastric cancer via inactivating IFNγ/STAT1 signaling.
    Jiang L; Liu JY; Shi Y; Tang B; He T; Liu JJ; Fan JY; Wu B; Xu XH; Zhao YL; Qian F; Cui YH; Yu PW
    J Exp Clin Cancer Res; 2019 May; 38(1):206. PubMed ID: 31113461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PRL-3 promotes gastric cancer migration and invasion through a NF-κB-HIF-1α-miR-210 axis.
    Zhang C; Tian W; Meng L; Qu L; Shou C
    J Mol Med (Berl); 2016 Apr; 94(4):401-15. PubMed ID: 26548949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-136 inhibits gastric cancer-specific peritoneal metastasis by targeting HOXC10.
    Zheng J; Ge P; Liu X; Wei J; Wu G; Li X
    Tumour Biol; 2017 Jun; 39(6):1010428317706207. PubMed ID: 28656883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of miRNA‑301a‑3p promotes tumor progression in gastric cancer by suppressing NKRF and activating NF‑κB signaling.
    Xu X; Xia Y; Ma J; Li W; Niu N; Li X; Tao H; Xu J; He X
    Int J Oncol; 2020 Aug; 57(2):522-532. PubMed ID: 32468020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A positive feedback loop consisting of C12orf59/NF-κB/CDH11 promotes gastric cancer invasion and metastasis.
    Zhang JX; He WL; Feng ZH; Chen DL; Gao Y; He Y; Qin K; Zheng ZS; Chen C; Weng HW; Yun M; Ye S; Xu RH; Xie D
    J Exp Clin Cancer Res; 2019 Apr; 38(1):164. PubMed ID: 30987656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AEBP1 promotes epithelial-mesenchymal transition of gastric cancer cells by activating the NF-κB pathway and predicts poor outcome of the patients.
    Liu JY; Jiang L; Liu JJ; He T; Cui YH; Qian F; Yu PW
    Sci Rep; 2018 Aug; 8(1):11955. PubMed ID: 30097586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homeodomain-containing gene 10 inhibits cell apoptosis and promotes cell invasion and migration in osteosarcoma cell lines.
    Xiong W; Zhou Q; Liu G; Liu XS; Li XY
    Tumour Biol; 2017 May; 39(5):1010428317697566. PubMed ID: 28474998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homeobox C10 Influences on the Malignant Phenotype of Gastric Cancer Cell Lines and its Elevated Expression Positively Correlates with Recurrence and Poor Survival.
    Miwa T; Kanda M; Umeda S; Tanaka H; Tanaka C; Kobayashi D; Suenaga M; Hayashi M; Yamada S; Nakayama G; Koike M; Kodera Y
    Ann Surg Oncol; 2019 May; 26(5):1535-1543. PubMed ID: 30673899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocyte growth factor (HGF) upregulates heparanase expression via the PI3K/Akt/NF-κB signaling pathway for gastric cancer metastasis.
    Hao NB; Tang B; Wang GZ; Xie R; Hu CJ; Wang SM; Wu YY; Liu E; Xie X; Yang SM
    Cancer Lett; 2015 May; 361(1):57-66. PubMed ID: 25727320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway.
    Guan Y; He Y; Lv S; Hou X; Li L; Song J
    J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NETO2 promotes invasion and metastasis of gastric cancer cells via activation of PI3K/Akt/NF-κB/Snail axis and predicts outcome of the patients.
    Liu JY; Jiang L; He T; Liu JJ; Fan JY; Xu XH; Tang B; Shi Y; Zhao YL; Qian F; Wang Y; Cui YH; Yu PW
    Cell Death Dis; 2019 Feb; 10(3):162. PubMed ID: 30770791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha B-crystallin promotes the invasion and metastasis of gastric cancer via NF-κB-induced epithelial-mesenchymal transition.
    Chen D; Cao G; Qiao C; Liu G; Zhou H; Liu Q
    J Cell Mol Med; 2018 Jun; 22(6):3215-3222. PubMed ID: 29566309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of NF-κB signaling pathway in the regulation of PRKAA1-mediated tumorigenesis in gastric cancer.
    Zhang Y; Zhou X; Zhang Q; Zhang Y; Wang X; Cheng L
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3677-3686. PubMed ID: 31841039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HOXC10 up-regulation contributes to human thyroid cancer and indicates poor survival outcome.
    Feng X; Li T; Liu Z; Shi Y; Peng Y
    Mol Biosyst; 2015 Nov; 11(11):2946-54. PubMed ID: 26279264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDH17 alters MMP-2 expression via canonical NF-κB signalling in human gastric cancer.
    Jiang XJ; Lin J; Cai QH; Zhao JF; Zhang HJ
    Gene; 2019 Jan; 682():92-100. PubMed ID: 29783070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HOXB7 overexpression promotes cell proliferation and correlates with poor prognosis in gastric cancer patients by inducing expression of both AKT and MARKs.
    He X; Liu Z; Xia Y; Xu J; Lv G; Wang L; Ma T; Jiang L; Mou Y; Jiang X; Ma J; Zhao Z; Ni H; Xu W; Ru G; Huang D; Tao H
    Oncotarget; 2017 Jan; 8(1):1247-1261. PubMed ID: 27901487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.